immunity News and Research

RSS

New study reveals the genetic mechanism behind severe staphylococcal infections

A common culprit of skin and respiratory infections, Staphylococcus aureus is highly unpredictable. Between 20 and 30 percent of people carry quiet colonies on their skin and in their nostrils, which seldom cause problems beyond the occasional rash.

19 May 2022

New insights on avian influenza spillover and global spread

When it comes to avian influenza, more commonly known as bird flu, all birds are not created equal.

19 May 2022

Scientists investigate relevance of COVID-19 vaccine-mediated T cell immunity to SARS-CoV-2 variants

Researchers showed the significance of T cell-based immunity against the SARS-CoV-2 variants exhibiting evasion to antibody-centric immunity.

19 May 2022

Impact of COVID-19 second booster vaccine on all-cause death among older cohorts

Scientists illustrated that the second booster dose of the SARS-CoV-2 vaccinations lowered all-cause death in the long-term care home residents and those aged 80 years or older.

19 May 2022

sCPD9: a SARS-CoV-2 nasal vaccine candidate that may have superior efficacy

...

19 May 2022

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

By uniting research from 8 cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2.

19 May 2022

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Researchers evaluated the humoral and T lymphocyte immune responses against SARS-CoV-2 variants of concern among mild COVID-19 convalescent patients in South Australia.

19 May 2022

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

In a new study, researchers evaluated the ability of vaccine-induced antibodies to recognize and neutralize various SARS-CoV-2 variants of concern in SARS-CoV-2-naive health care workers in the Netherlands.

19 May 2022

Study investigates the detection of antibodies against SARS-CoV-2 in urine

Researchers developed an enzyme-linked immunosorbent assay to detect antibodies against SARS-CoV-2 in urine samples.

19 May 2022

COVID-19 mortality strongly predicted by autoimmunity to type I interferons and advancing age

In a recent study published in the journal PNAS, researchers estimated the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) and relative risk of death (RRD) among subjects across ages.

19 May 2022

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

In a recent study posted to the medRxiv* preprint server, researchers estimated the humoral immunity imparted by the two/three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in solid organ transplant recipients (SOTRs).

18 May 2022

Study in India shows SARS-CoV-2 Omicron is evolving

In a recent study posted to the bioRxiv* pre-print server, researchers analyzed the whole-genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) collected from SARS-CoV-2-infected patients in Delhi, India, between June 2021 and March 2022.

18 May 2022

Only some coronaviruses found to have pandemic-causing potential

In a new study, scientists focused on resolving the mystery of why some coronaviruses have the potential of causing a pandemic while others do not.

18 May 2022

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

In a new study, researchers evaluated the BNT162b2 coronavirus disease 2019 mRNA vaccine (antigen)-specific immune response among myeloid dysplastic syndrome and chronic lymphocytic leukemia patients.

18 May 2022

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Researchers assessed the vaccine-induced humoral responses against SARS-CoV-2 post four different vaccination regimens comprising homologous and heterologous vaccine doses.

18 May 2022

How better ventilation can help ‘covid-proof’ your home

For two years, you beat the odds. You masked, kept your distance, got your shots.

18 May 2022

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

A research team at LKS Faculty of Medicine, The University of Hong Kong discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergised with radiotherapy can control nasopharyngeal carcinoma (NPC) by overcoming the radioresistance of NPC cancer stem cells (CSCs) and preserve their tumor-killing and T cell-promoting activities in the immunosuppressive NPC microenvironment.

18 May 2022

Discovery of a potent SARS-CoV-2 RBD specific human monoclonal antibody

A recent article posted to the bioRxiv* preprint server demonstrated structural underpinnings of the neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants by 002-S21F2, an extensive SARS-CoV-2 neutralizing antibody.

18 May 2022

Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes

A new study published in the journal Life Sciences has focused on examining the effects of ORF8 and ORF10 genes and SARS-CoV-2 Membrane (M) protein on apoptosis.

17 May 2022

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

A new research paper was published on the cover of Aging (Aging-US) Volume 14, Issue 9, entitled, "Single-cell transcriptomics reveals age-resistant maintenance of cell identities, stem cell compartments and differentiation trajectories in long-lived naked mole-rats skin."

17 May 2022

immunity News and Research

New study reveals the genetic mechanism behind severe staphylococcal infections

New insights on avian influenza spillover and global spread

Scientists investigate relevance of COVID-19 vaccine-mediated T cell immunity to SARS-CoV-2 variants

Impact of COVID-19 second booster vaccine on all-cause death among older cohorts

sCPD9: a SARS-CoV-2 nasal vaccine candidate that may have superior efficacy

New study helps to better understand re-infection rates and correlates of protection for SARS-CoV-2

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Neutralizing antibody responses induced by COVID-19 vaccines against SARS-CoV-2 variants

Study investigates the detection of antibodies against SARS-CoV-2 in urine

COVID-19 mortality strongly predicted by autoimmunity to type I interferons and advancing age

Immunity conferred by COVID-19 vaccines in solid organ transplant recipients

Study in India shows SARS-CoV-2 Omicron is evolving

Only some coronaviruses found to have pandemic-causing potential

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

How better ventilation can help ‘covid-proof’ your home

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

Discovery of a potent SARS-CoV-2 RBD specific human monoclonal antibody

Impact of cannabidiol on cellular innate immune responses to SARS-CoV-2 genes

Molecular RNA profile of naked mole-rats reveals new insights on skin aging

Industry Focus eBook - Cell biology (5th edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News